ResearcherChinese Academy of SciencesNo recent work listed
Zhiguo Yu
Matched on ORCID iD 0000-0003-1493-8932; OpenAlex author ID A5101443569. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 3
- Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Cancer. Co-author DOI 10.1021/acsnano.3c00674↗
- Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy. First author DOI 10.1021/acsami.2c00111↗
- Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nanoplatform. Co-author DOI 10.1002/smll.201907233↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jianlin Shi · 3 shared papers, 2020–2023 · strength 0.53
- Paper Dual Tumor Exosome Biomarker Co-recognitions Based Nanoliquid Biopsy for the Accurate Early Diagnosis of Pancreatic Can… DOI 10.1021/acsnano.3c00674↗
- Paper Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy. DOI 10.1021/acsami.2c00111↗
- Paper Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nan… DOI 10.1002/smll.201907233↗
- Yingying Xu · 2 shared papers, 2020–2022 · strength 0.31
- Yingbin Liu · 1 shared paper, 2023 · strength 0.22
- Dalong Ni · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.